Vitamin D and immunomodulation: Is it time to change the reference values?

Annals of Clinical and Laboratory Science

Volumn 47, Issue 4, 2017, Pages 508-510

  Bivona, Giulia ^a   Agnello, Luisa ^a   Ciaccio, Marcello ^a,b  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN D;

DRUG EFFECTS; HUMAN; IMMUNOMODULATION; REFERENCE VALUE;

HUMANS; IMMUNOMODULATION; REFERENCE VALUES; VITAMIN D;

EID: 85027371465     PISSN: 00917370     EISSN: 15508080     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Reichel H, Norman AW. Systemic effects of vitamin D. Annu Rev Med,1989; 40:71-8
2. Wöbke TK, Sorg BL, Steinhilber D. Vitamin D in inflammatory diseases. Front Physiol, 2014; 2; 5:244
3. Bouillon R, Lieben L, Mathieu C et al. Vitamin D actions: lessons from VDR and Cyp27b1 null mice. Pediatr Endocrinol Rev, 2013;10(S2):354-66
4. Fernandes de Abreu DA, Eyles D, Féron F. Vitamin D, a neuroimmunomodulator: implications for neurodegenerative and autoimmune diseases. Psychoneuroendocrinology, 2009; 34S: 265-77
5. Baeke F, Takiishi T, Horf H. Vitamin D: modulator of the immune system. Curr Opin Pharmacol, 2010; 4: 482-96
6. Li MO, Flavell RA. Contextual regulation of inflammation: a duet by transforming growth factor-beta and interleukin-10. Immunity, 2008; 28: 468-76
7. Wang TT, Tavera-Mendoza LE, Laperriere D, Libby E, MacLeod NB, Nagai Y, Bourdeau V, Konstorum A, Lallemant B, Zhang R, Mader S, White JH. Large-scale in silico and microarray-based identification of 1, 25-dihydroxivitamin D3 target genes. Mol Endocrinol, 2005; 19: 2685-95
8. Khanal RC, Peters TM, Smith NM, Nemere I. membrane receptor-initiated signaling in 1, 25(OH)2D3-stimulated calcium uptake in intestinal epithelial cells. J Cell Biochem, 2008; 105: 1109-16
9. Mizwicki MT, Norman AW. The vitaminDsterol-vitamin D receptor ensemble model offers unique insights into both genomic and rapid-response signaling. Sci Signal, 2009; 2(75) re4
10. Tuttolomondo A, Di Raimondo D, Di Sciacca R, Casuccio A, Bivona G, Bellia C, Barreca L, Serio A, D'Aguanno G, Ciaccio M, Licata G, Pinto A. Fetuin-A and CD 40 Ligand plasma levels in acute ischaemic stroke: differences in relation to TOAST subtype and correlation with clinical and laboratory variables. Atherosclerosis. 2010; 208(1): 290-6
11. Tuttolomondo A1, La Placa S, Di Raimondo D, Bellia C, Caruso A, Lo Sasso B, Guercio G, Diana G, Ciaccio M, Licata G, Pinto A. Adiponectin, resistin and IL-6 plasma levels in subjects with diabetic foot and possible correlations with clinical variables and cardiovascular co-morbidity. Cardiovasc Diabetol. 2010; 13; 9:50
12. Abbas MA. Physiological functions of vitamin D in adipose tissue. J Steroid Biochem Mol Biol, 2016; pii: S0960-0760(16)30219-9. doi: 10.1016/j.jsbmb.2016.08.004
13. Bivona G, Agnello L, Pivetti A, Milano S, Scazzone C, Sasso BL, Ciaccio M. Association between hypovitaminosis D and systemic sclerosis: true or fake? Clinica Chimica Acta, 2016;458 115-9
14. Burton JM, Costello FEJ. VitaminDin multiple sclerosis and central nervous system demyelinating disease-a review. Neurophtalmol, 2015; 35: 194-200
15. Agnello L, Scazzone C, Ragonese P, Salemi G, Lo Sasso B, Schillaci R, Musso G, Bellia C, Ciaccio M. Vitamin D receptor polymorphisms and 25-hydroxivitamin D in a group of Sicilian multiple sclerosis patients. Neurol Sci, 2016; 37: 261-7
16. Waterhouse JC, Perez T, Albert PJ. Reversing bacteria-induced vitamin D receptor dysfunction is key to autoimmune disease. Ann NY Acad Sci, 2009; 1173: 757-65
17. Marques CD, Dantas AT, Fragoso TS, Duarte AL. The importance of vitamin D levels in autoimmune diseases. Bras J Rheumatol, 2010; 50(1): 67-80
18. Leventis P, Patel S. Clinical aspects of vitamin D in the management of rheumatoid arthritis. Rheumatology, 2008; 47: 1617-21
19. Bandeira F, Griz L, Dreyer P, Eufrazino C, Bandeira C, Freese E. Vitamin D deficiency: a global perspective. Arq Bras Endocrinol Metabol, 2006; 50(4): 640-6
20. Cantorna MT, Mahon B. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Bio Med, 2004; 229(11): 1136-42
21. Ruiz-Irastorza G, Egurbide MV, Olivares N, Martinez-Berriotxoa A, Aguirre C. Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences. Rheumatology, 2008; 47: 920-3
22. Lamb EJ, Wong T, Smith DJ, Simpson DE, Coakley AJ, Moniz C, Muller AF. Metabolic bone disease is present at diagnosis in patients with inflammatory bowel disease. Aliment Pharmacol Ther, 2002; 16(11): 1985-92